ENVB vs. VT

In the year-to-date period, ENVB achieves a -78.05% return, which is significantly lower than VT's 5.36% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Enveric Biosciences Inc (ENVB) and Vanguard Total World Stock ETF (VT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ENVB Sharpe Ratio is -0.64, which is lower than the VT Sharpe Ratio of 0.78. The chart below compares the historical Sharpe Ratios of ENVB and VT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

ENVB has not paid dividends to shareholders, while VT's dividend yield for the trailing twelve months is around 1.83%.

The maximum ENVB drawdown since its inception was -100.00%, which is greater than VT's maximum drawdown of -50.27%. Use the drawdown chart below to compare losses from any high point for ENVB and VT.

Enveric Biosciences Inc (ENVB) has a higher volatility of 20.50% compared to Vanguard Total World Stock ETF (VT) at 3.82%. This indicates that ENVB's price experiences larger fluctuations and is considered to be riskier than VT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.